Literature DB >> 17278389

Linking innate to adaptive immunity through dendritic cells.

Ralph M Steinman1.   

Abstract

The function of dendritic cells (DCs) in linking innate to adaptive immunity is often summarized with two terms. DCs are sentinels, able to capture, process and present antigens and to migrate to lymphoid tissues to select rare, antigen-reactive T cell clones. DCs are also sensors, responding to a spectrum of environmental cues by extensive differentiation or maturation. The type of DC and the type of maturation induced by different stimuli influences the immunological outcome, such as the differentiation of Thl vs. Th2 T cells. Here we summarize the contributions of DCs to innate defences, particularly the production of immune enhancing cytokines and the activation of innate lymphocytes. Then we outline three innate features of DCs that influence peripheral tolerance and lead to adaptive immunity: a specialized endocytic system for antigen capture and processing, location and movements in vivo, and maturation in response to an array of stimuli. A new approach to the analysis of DC biology is to target antigens selectively to maturing DCs in vivo. This leads to stronger, more prolonged and broader (many immunogenic peptides) immunity by both T cells and B cells.

Mesh:

Year:  2006        PMID: 17278389

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  42 in total

Review 1.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 2.  Innate immunity and inflammation--two facets of the same anti-infectious reaction.

Authors:  M Si-Tahar; L Touqui; M Chignard
Journal:  Clin Exp Immunol       Date:  2009-03-02       Impact factor: 4.330

Review 3.  Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

Authors:  Tristan de Jesus; Sudhanshu Shukla; Parameswaran Ramakrishnan
Journal:  Cell Immunol       Date:  2018-06-02       Impact factor: 4.868

4.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

Review 5.  Emerging roles for myeloid immune cells in bone metastasis.

Authors:  Massar Alsamraae; Leah M Cook
Journal:  Cancer Metastasis Rev       Date:  2021-04-14       Impact factor: 9.264

6.  Oxidized base 8-oxoguanine, a product of DNA repair processes, contributes to dendritic cell activation.

Authors:  Kitti Pázmándi; Máté Sütő; Tünde Fekete; Aliz Varga; Eszter Boldizsár; István Boldogh; Attila Bácsi
Journal:  Free Radic Biol Med       Date:  2019-08-10       Impact factor: 7.376

7.  IFN-beta improves BCG immunogenicity by acting on DC maturation.

Authors:  Elena Giacomini; Maria Elena Remoli; Valérie Gafa; Manuela Pardini; Lanfranco Fattorini; Eliana M Coccia
Journal:  J Leukoc Biol       Date:  2008-12-04       Impact factor: 4.962

8.  Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Authors:  Mark J Bluth; Lisa C Zaba; Dariush Moussai; Mayte Suárez-Fariñas; Helen Kaporis; Linda Fan; Katherine C Pierson; Traci R White; Alexander Pitts-Kiefer; Judilyn Fuentes-Duculan; Emma Guttman-Yassky; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

9.  TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Authors:  Nasreen Vohra; Monique Verhaegen; Lisa Martin; Amy Mackay; Shari Pilon-Thomas
Journal:  Cancer Immunol Immunother       Date:  2010-05       Impact factor: 6.968

10.  CD1d activation and blockade: a new antitumor strategy.

Authors:  Michele W L Teng; Simon Yue; Janelle Sharkey; Mark A Exley; Mark J Smyth
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.